| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.612 | 0.012 | 0.612 | Immunosuppressant | 0.61 0.012 CID_113623 | ||
| 0.544 | 0.004 | 0.544 | Amyloid beta precursor protein antagonist | 0.315 0.014 CID_113623 | ||
| 0.59 | 0.051 | 0.69 | Apoptosis agonist | 0.69 0.033 CID_113623 | CID_113623 | |
| 0.547 | 0.009 | 0.547 | Hypolipemic | 0.5 0.013 CID_113623 | ||
| 0.532 | 0.04 | 0.705 | Transcription factor NF kappa B inhibitor | 0.705 0.02 CID_113623 | CID_113623 | |
| 0.506 | 0.057 | 0.506 | Caspase 9 stimulant | 0.488 0.065 CID_113623 | ||
| 0.509 | 0.084 | 0.611 | Antiinflammatory | 0.611 0.05 CID_113623 | CID_113623 | |
| 0.393 | 0.051 | 0.546 | Cholesterol antagonist | 0.546 0.026 CID_113623 | CID_113623 | |
| 0.375 | 0.035 | 0.375 | Calcium channel activator | 0.337 0.059 CID_113623 | ||
| 0.382 | 0.044 | 0.382 | Apoptosis antagonist | 0.208 0.169 CID_113623 | ||
| 0.359 | 0.035 | 0.384 | Sodium/bile acid cotransporter inhibitor | 0.384 0.022 CID_113623 | CID_113623 | |
| 0.353 | 0.031 | 0.436 | Nitric oxide antagonist | 0.436 0.021 CID_113623 | CID_113623 | |
| 0.29 | 0.009 | 0.347 | Nav1.1 sodium channel blocker | 0.347 0.005 CID_113623 | CID_113623 | |
| 0.359 | 0.081 | 0.359 | GABA C receptor rho-3 antagonist | |||
| 0.306 | 0.042 | 0.306 | 5 Hydroxytryptamine uptake stimulant | 0.249 0.081 CID_113623 | ||
| 0.278 | 0.019 | 0.365 | Alpha-N-acetylglucosaminidase inhibitor | 0.365 0.011 CID_113623 | CID_113623 | |
| 0.276 | 0.021 | 0.335 | Phospholipase C inhibitor | 0.335 0.015 CID_113623 | CID_113623 | |
| 0.291 | 0.037 | 0.291 | Tyrosine 3 hydroxylase inhibitor | 0.225 0.096 CID_113623 | ||
| 0.278 | 0.025 | 0.278 | Neurotrophic factor enhancer | 0.271 0.028 CID_113623 | ||
| 0.369 | 0.13 | 0.369 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.263 | 0.029 | 0.289 | Lipocortins synthesis antagonist | 0.289 0.023 CID_113623 | CID_113623 | |
| 0.237 | 0.009 | 0.247 | Arachidonic acid antagonist | 0.247 0.006 CID_113623 | CID_113623 | |
| 0.227 | 0.005 | 0.227 | Interleukin 2 antagonist | 0.138 0.025 CID_113623 | ||
| 0.263 | 0.045 | 0.263 | Anesthetic general | 0.258 0.047 CID_113623 | ||
| 0.233 | 0.031 | 0.315 | Protein kinase stimulant | 0.315 0.015 CID_113623 | CID_113623 | |
| 0.276 | 0.078 | 0.276 | 5 Hydroxytryptamine release stimulant | 0.183 0.138 CID_113623 | ||
| 0.204 | 0.008 | 0.204 | Macrophage colony-stimulating factor 1 receptor antagonist | |||
| 0.202 | 0.013 | 0.22 | Adenylate cyclase stimulant | 0.22 0.007 CID_113623 | CID_113623 | |
| 0.241 | 0.056 | 0.245 | RNA-directed DNA polymerase inhibitor | 0.245 0.052 CID_113623 | CID_113623 | |
| 0.188 | 0.005 | 0.194 | Ca2+-transporting ATPase inhibitor | 0.194 0.004 CID_113623 | CID_113623 | |
| 0.196 | 0.014 | 0.196 | GABA C receptor antagonist | 0.131 0.042 CID_113623 | ||
| 0.203 | 0.021 | 0.203 | Farnesoid X receptor antagonist | 0.179 0.029 CID_113623 | ||
| 0.185 | 0.012 | 0.185 | Prolactin inhibitor | 0.133 0.03 CID_113623 | ||
| 0.212 | 0.045 | 0.212 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.19 | 0.022 | 0.24 | Microtubule formation inhibitor | 0.24 0.011 CID_113623 | CID_113623 | |
| 0.225 | 0.059 | 0.225 | Platelet adhesion inhibitor | |||
| 0.186 | 0.023 | 0.186 | Expectorant | 0.159 0.032 CID_113623 | ||
| 0.164 | 0.002 | 0.241 | Vanilloid 3 antagonist | 0.241 0.001 CID_113623 | CID_113623 | |
| 0.307 | 0.158 | 0.307 | 5 Hydroxytryptamine release inhibitor | |||
| 0.174 | 0.026 | 0.174 | GABA C receptor agonist | 0.114 0.054 CID_113623 | ||
| 0.191 | 0.045 | 0.191 | ATPase inhibitor | 0.187 0.049 CID_113623 | ||
| 0.194 | 0.054 | 0.194 | Succinate dehydrogenase inhibitor | 0.157 0.1 CID_113623 | ||
| 0.158 | 0.019 | 0.22 | Vanilloid antagonist | 0.22 0.012 CID_113623 | CID_113623 | |
| 0.148 | 0.012 | 0.148 | Ornithine decarboxylase inhibitor | 0.135 0.017 CID_113623 | ||
| 0.167 | 0.035 | 0.167 | Cyclooxygenase 3 inhibitor | 0.155 0.044 CID_113623 | ||
| 0.142 | 0.01 | 0.142 | HIV-1 integrase inhibitor | |||
| 0.167 | 0.037 | 0.167 | Proteasome inhibitor | 0.114 0.071 CID_113623 | ||
| 0.23 | 0.105 | 0.23 | Gastrin inhibitor | |||
| 0.145 | 0.021 | 0.158 | Triose-phosphate isomerase inhibitor | 0.158 0.018 CID_113623 | CID_113623 | |
| 0.175 | 0.053 | 0.191 | Interferon gamma antagonist | 0.191 0.044 CID_113623 | CID_113623 | |
| 0.165 | 0.049 | 0.165 | Nav1.2 sodium channel blocker | 0.121 0.082 CID_113623 | ||
| 0.126 | 0.011 | 0.14 | Glycine receptor agonist | 0.14 0.008 CID_113623 | CID_113623 | |
| 0.138 | 0.026 | 0.236 | Androgen antagonist | 0.236 0.01 CID_113623 | CID_113623 | |
| 0.121 | 0.009 | 0.121 | Acetyl-CoA transferase inhibitor | 0.121 0.009 CID_113623 | ||
| 0.144 | 0.032 | 0.278 | Antineoplastic antibiotic | 0.278 0.011 CID_113623 | CID_113623 | |
| 0.17 | 0.059 | 0.189 | Melanin inhibitor | 0.189 0.046 CID_113623 | CID_113623 | |
| 0.148 | 0.039 | 0.148 | Ferrochelatase inhibitor | |||
| 0.134 | 0.028 | 0.146 | Anabolic | 0.146 0.02 CID_113623 | CID_113623 | |
| 0.148 | 0.046 | 0.166 | Cholesterol synthesis inhibitor | 0.166 0.037 CID_113623 | CID_113623 | |
| 0.211 | 0.111 | 0.211 | Interleukin agonist | 0.198 0.122 CID_113623 | ||
| 0.118 | 0.018 | 0.124 | Na+ K+ transporting ATPase inhibitor | 0.124 0.014 CID_113623 | CID_113623 | |
| 0.145 | 0.048 | 0.145 | Sphingosine 1-phosphate receptor 2 antagonist | |||
| 0.14 | 0.05 | 0.14 | Vanilloid 1 agonist | 0.128 0.07 CID_113623 | ||
| 0.143 | 0.053 | 0.18 | DNA polymerase I inhibitor | 0.18 0.035 CID_113623 | CID_113623 | |
| 0.095 | 0.006 | 0.095 | Prostaglandin EP3 antagonist | 0.045 0.011 CID_113623 | ||
| 0.191 | 0.104 | 0.191 | Nitric-oxide synthase stimulant | 0.187 0.113 CID_113623 | ||
| 0.154 | 0.069 | 0.154 | CF transmembrane conductance regulator agonist | 0.149 0.078 CID_113623 | ||
| 0.088 | 0.003 | 0.088 | Tubulin agonist | 0.082 0.003 CID_113623 | ||
| 0.112 | 0.027 | 0.144 | Phosphofructokinase-1 inhibitor | 0.144 0.019 CID_113623 | CID_113623 | |
| 0.2 | 0.117 | 0.2 | Superoxide dismutase inhibitor | |||
| 0.122 | 0.042 | 0.151 | UDP-glucose 4-epimerase inhibitor | 0.151 0.029 CID_113623 | CID_113623 | |
| 0.226 | 0.148 | 0.226 | Vasodilator, peripheral | 0.225 0.149 CID_113623 | ||
| 0.105 | 0.028 | 0.113 | Glycine receptor antagonist | 0.113 0.022 CID_113623 | CID_113623 | |
| 0.085 | 0.009 | 0.122 | Acetyl-CoA transferase 2 inhibitor | 0.122 0.004 CID_113623 | CID_113623 | |
| 0.187 | 0.112 | 0.187 | Aldehyde oxidase inhibitor | 0.164 0.127 CID_113623 | ||
| 0.142 | 0.068 | 0.142 | Pregnane X receptor agonist | 0.128 0.106 CID_113623 | ||
| 0.125 | 0.052 | 0.125 | TRPA1 agonist | |||
| 0.097 | 0.029 | 0.097 | Estrogen-related receptor beta agonist | 0.094 0.032 CID_113623 | ||
| 0.09 | 0.024 | 0.11 | Carbamoyl phosphate synthetase inhibitor | 0.11 0.018 CID_113623 | CID_113623 | |
| 0.196 | 0.13 | 0.216 | DNA synthesis inhibitor | 0.216 0.1 CID_113623 | CID_113623 | |
| 0.106 | 0.041 | 0.106 | Phosphodiesterase 6D inhibitor | |||
| 0.108 | 0.044 | 0.108 | Lanosterol 14 alpha demethylase inhibitor | 0.103 0.052 CID_113623 | ||
| 0.084 | 0.02 | 0.084 | Glutamate (mGluR6) antagonist | 0.081 0.023 CID_113623 | ||
| 0.139 | 0.077 | 0.139 | Heat shock protein 70 antagonist | 0.133 0.106 CID_113623 | ||
| 0.073 | 0.011 | 0.077 | Adenylate cyclase 1 inhibitor | 0.077 0.009 CID_113623 | CID_113623 | |
| 0.112 | 0.051 | 0.129 | Adenylate kinase inhibitor | 0.129 0.037 CID_113623 | CID_113623 | |
| 0.182 | 0.12 | 0.182 | Vasodilator | |||
| 0.221 | 0.162 | 0.276 | Vasodilator, coronary | 0.276 0.109 CID_113623 | CID_113623 | |
| 0.107 | 0.048 | 0.107 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.104 0.05 CID_113623 | ||
| 0.146 | 0.09 | 0.178 | Growth hormone agonist | 0.178 0.068 CID_113623 | CID_113623 | |
| 0.099 | 0.043 | 0.099 | Glutamate release inhibitor | |||
| 0.122 | 0.066 | 0.122 | Anesthetic local | |||
| 0.142 | 0.087 | 0.142 | Protein-tyrosine phosphatase inhibitor | |||
| 0.115 | 0.06 | 0.123 | Mucolytic | 0.123 0.052 CID_113623 | CID_113623 | |
| 0.141 | 0.086 | 0.141 | GABA C receptor rho-2 antagonist | |||
| 0.061 | 0.008 | 0.061 | Alpha 1L adrenoreceptor agonist | |||
| 0.123 | 0.071 | 0.123 | Nav1.3 sodium channel blocker | |||
| 0.087 | 0.035 | 0.087 | Epoxide hydrolase inhibitor | |||
| 0.097 | 0.047 | 0.112 | NADH dehydrogenase inhibitor | 0.112 0.033 CID_113623 | CID_113623 | |
| 0.062 | 0.013 | 0.063 | Microtubule stabilization | 0.063 0.011 CID_113623 | CID_113623 | |
| 0.145 | 0.096 | 0.383 | Interleukin 6 antagonist | 0.383 0.008 CID_113623 | CID_113623 | |
| 0.13 | 0.081 | 0.13 | Nav1.6 sodium channel blocker | |||
| 0.064 | 0.016 | 0.075 | Glucose-6-phosphate isomerase inhibitor | 0.075 0.01 CID_113623 | CID_113623 | |
| 0.071 | 0.024 | 0.082 | Protein 50S ribosomal subunit inhibitor | 0.082 0.019 CID_113623 | CID_113623 | |
| 0.058 | 0.01 | 0.058 | Acetyl-CoA transferase 1 inhibitor | 0.051 0.016 CID_113623 | ||
| 0.075 | 0.028 | 0.087 | Argininosuccinate synthase inhibitor | 0.087 0.023 CID_113623 | CID_113623 | |
| 0.211 | 0.164 | 0.214 | Antithrombotic | 0.214 0.16 CID_113623 | CID_113623 | |
| 0.091 | 0.045 | 0.091 | mTOR complex 2 inhibitor | |||
| 0.088 | 0.042 | 0.088 | CC chemokine 5 receptor agonist | |||
| 0.113 | 0.068 | 0.113 | Protein-tyrosine phosphatase 1B inhibitor | |||
| 0.073 | 0.028 | 0.082 | Androgen agonist | 0.082 0.023 CID_113623 | CID_113623 | |
| 0.115 | 0.07 | 0.115 | Transcription factor STAT6 inhibitor | |||
| 0.071 | 0.026 | 0.071 | Calcium channel P-type blocker | 0.061 0.054 CID_113623 | ||
| 0.135 | 0.09 | 0.135 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.083 | 0.042 | 0.092 | Glutamate dehydrogenase inhibitor | 0.092 0.035 CID_113623 | CID_113623 | |
| 0.091 | 0.05 | 0.091 | Granulocyte macrophage colony stimulating factor agonist | |||
| 0.101 | 0.061 | 0.101 | GABA C receptor rho-1 antagonist | |||
| 0.065 | 0.026 | 0.065 | Ryanodine receptor antagonist | 0.062 0.033 CID_113623 | ||
| 0.063 | 0.024 | 0.063 | Pregnane X receptor antagonist | 0.055 0.045 CID_113623 | ||
| 0.063 | 0.024 | 0.063 | Aconitate hydratase inhibitor | |||
| 0.085 | 0.047 | 0.085 | Ca(v)3.1 blocker | |||
| 0.098 | 0.059 | 0.098 | DNA directed RNA polymerase inhibitor | |||
| 0.108 | 0.07 | 0.108 | Monophenol monooxygenase inhibitor | |||
| 0.129 | 0.092 | 0.129 | Peroxidase inhibitor | |||
| 0.078 | 0.041 | 0.078 | Purinergic P2X2 antagonist | |||
| 0.04 | 0.005 | 0.04 | Nicotinic acid receptor 2 antagonist | |||
| 0.065 | 0.03 | 0.071 | Acyl-CoA dehydrogenase inhibitor | 0.071 0.026 CID_113623 | CID_113623 | |
| 0.055 | 0.022 | 0.055 | Cholesterol esterase inhibitor | |||
| 0.108 | 0.075 | 0.108 | Photosensitizer | |||
| 0.062 | 0.032 | 0.074 | Lipocortins synthesis agonist | 0.074 0.017 CID_113623 | CID_113623 | |
| 0.159 | 0.129 | 0.175 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.175 0.1 CID_113623 | CID_113623 | |
| 0.031 | 0.003 | 0.036 | Telomerase stimulant | 0.036 0.002 CID_113623 | CID_113623 | |
| 0.161 | 0.134 | 0.161 | Cyclic AMP phosphodiesterase inhibitor | |||
| 0.074 | 0.048 | 0.074 | Aminopeptidase I inhibitor | 0.065 0.06 CID_113623 | ||
| 0.033 | 0.008 | 0.036 | Hedgehog signaling activator | 0.036 0.006 CID_113623 | CID_113623 | |
| 0.047 | 0.025 | 0.047 | Histamine H2 receptor agonist | |||
| 0.059 | 0.036 | 0.075 | Alcohol oxidase inhibitor | 0.075 0.026 CID_113623 | CID_113623 | |
| 0.074 | 0.052 | 0.074 | Vanilloid 4 agonist | |||
| 0.094 | 0.073 | 0.094 | Glutamate (mGluR7) agonist | |||
| 0.056 | 0.036 | 0.056 | Dihydroorotate oxidase inhibitor | |||
| 0.21 | 0.19 | 0.21 | Histamine release inhibitor | |||
| 0.047 | 0.028 | 0.047 | Parathyroid hormone antagonist | 0.047 0.028 CID_113623 | ||
| 0.029 | 0.011 | 0.029 | Vanilloid 2 agonist | 0.028 0.013 CID_113623 | ||
| 0.072 | 0.054 | 0.072 | Porphobilinogen synthase inhibitor | |||
| 0.043 | 0.025 | 0.043 | Kainate receptor agonist | 0.041 0.028 CID_113623 | ||
| 0.09 | 0.072 | 0.093 | Creatine kinase inhibitor | 0.093 0.068 CID_113623 | CID_113623 | |
| 0.056 | 0.039 | 0.07 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.07 0.026 CID_113623 | CID_113623 | |
| 0.042 | 0.026 | 0.042 | Dopamine D5 agonist | |||
| 0.04 | 0.024 | 0.04 | Retinoid X receptor antagonist | |||
| 0.09 | 0.075 | 0.091 | Bile acid receptor antagonist | 0.091 0.071 CID_113623 | CID_113623 | |
| 0.04 | 0.026 | 0.04 | Membrane dipeptidase inhibitor | |||
| 0.036 | 0.021 | 0.036 | Retinoid X alpha receptor antagonist | |||
| 0.038 | 0.023 | 0.038 | Retinoid X receptor agonist | |||
| 0.079 | 0.065 | 0.121 | Thioredoxin reductase inhibitor | 0.121 0.016 CID_113623 | CID_113623 | |
| 0.033 | 0.02 | 0.033 | Glutamate (mGluR3) agonist | 0.031 0.025 CID_113623 | ||
| 0.044 | 0.03 | 0.044 | Geranyltranstransferase inhibitor | |||
| 0.078 | 0.065 | 0.078 | Inducible nitric-oxide synthase inhibitor | |||
| 0.042 | 0.029 | 0.042 | Oxytocin agonist | |||
| 0.057 | 0.044 | 0.059 | Biliverdin reductase inhibitor | 0.059 0.041 CID_113623 | CID_113623 | |
| 0.036 | 0.023 | 0.036 | Retinoid X alpha receptor agonist | |||
| 0.098 | 0.086 | 0.118 | Adenylate cyclase inhibitor | 0.118 0.069 CID_113623 | CID_113623 | |
| 0.022 | 0.01 | 0.022 | Retinoid X beta receptor antagonist | |||
| 0.096 | 0.084 | 0.096 | DOPA decarboxylase inhibitor | |||
| 0.068 | 0.056 | 0.068 | Cathepsin G inhibitor | |||
| 0.084 | 0.073 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | |||
| 0.034 | 0.024 | 0.041 | Fumarate hydratase inhibitor | 0.041 0.018 CID_113623 | CID_113623 | |
| 0.047 | 0.037 | 0.047 | HCV NS3/NS4A protease inhibitor | |||
| 0.032 | 0.021 | 0.032 | Cholesterol ester transfer protein antagonist | |||
| 0.018 | 0.009 | 0.02 | Vitamin D receptor agonist | 0.02 0.007 CID_113623 | CID_113623 | |
| 0.022 | 0.013 | 0.022 | Imidazoline I1 receptor antagonist | |||
| 0.07 | 0.061 | 0.07 | Phosphodiesterase VI inhibitor | |||
| 0.076 | 0.068 | 0.076 | Calcium antagonist | |||
| 0.071 | 0.063 | 0.071 | Keratolytic | 0.069 0.067 CID_113623 | ||
| 0.036 | 0.03 | 0.036 | Glutamate (mGluR8) agonist | |||
| 0.026 | 0.019 | 0.034 | Sodium/glucose cotransporter 2 inhibitor | 0.034 0.01 CID_113623 | CID_113623 | |
| 0.028 | 0.022 | 0.033 | Purinergic P2Y15 antagonist | 0.033 0.013 CID_113623 | CID_113623 | |
| 0.071 | 0.065 | 0.071 | GABA B receptor agonist | |||
| 0.018 | 0.012 | 0.018 | Nicotinic acid receptor 1 antagonist | |||
| 0.033 | 0.027 | 0.033 | Glucose-dependent insulinotropic receptor agonist | |||
| 0.05 | 0.044 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 CID_113623 | CID_113623 | |
| 0.047 | 0.041 | 0.047 | Squalene epoxidase inhibitor | |||
| 0.039 | 0.034 | 0.039 | Guanylate cyclase inhibitor | |||
| 0.083 | 0.079 | 0.083 | Aminopeptidase B inhibitor | |||
| 0.025 | 0.02 | 0.03 | Sodium/glucose cotransporter inhibitor | 0.03 0.011 CID_113623 | CID_113623 | |
| 0.032 | 0.028 | 0.039 | HMG CoA reductase inhibitor | 0.039 0.017 CID_113623 | CID_113623 | |
| 0.215 | 0.212 | 0.434 | Antibacterial | 0.434 0.063 CID_113623 | CID_113623 | |
| 0.065 | 0.064 | 0.065 | Phospholipase D inhibitor | |||
| 0.029 | 0.027 | 0.03 | ATP citrate lysase inhibitor | 0.03 0.025 CID_113623 | CID_113623 | |
| 0.018 | 0.016 | 0.02 | Antibiotic Anthracycline-like | 0.02 0.01 CID_113623 | CID_113623 | |
| 0.024 | 0.027 | 0.061 | Motilin receptor antagonist | 0.061 0.004 CID_113623 | CID_113623 | |
| 0.019 | 0.024 | 0.022 | Vitamin D receptor antagonist | 0.022 0.015 CID_113623 | CID_113623 | |
| 0.017 | 0.029 | 0.021 | Prostaglandin F2 alpha agonist | 0.021 0.018 CID_113623 | CID_113623 | |
| 0.101 | 0.114 | 0.196 | Lipid peroxidase inhibitor | 0.196 0.043 CID_113623 | CID_113623 | |
| 0.076 | 0.089 | 0.105 | ATPase (Vacuolar H+) inhibitor | 0.105 0.034 CID_113623 | CID_113623 | |
| 0.005 | 0.022 | 0.019 | Antibiotic Macrolide-like | 0.019 0.007 CID_113623 | CID_113623 | |
| 0.033 | 0.055 | 0.047 | Mannosidase inhibitor | 0.047 0.029 CID_113623 | CID_113623 | |
| 0.093 | 0.116 | 0.102 | Interleukin 8 antagonist | 0.102 0.093 CID_113623 | CID_113623 | |
| 0.015 | 0.041 | 0.035 | RNA-directed RNA polymerase stimulant | 0.035 0.018 CID_113623 | CID_113623 | |
| 0.07 | 0.1 | 0.08 | Transcription factor NF kappa B stimulant | 0.08 0.071 CID_113623 | CID_113623 | |
| 0.026 | 0.07 | 0.05 | Liver X receptor alpha agonist | 0.05 0.019 CID_113623 | CID_113623 | |
| 0.07 | 0.12 | 0.091 | T cell inhibitor | 0.091 0.036 CID_113623 | CID_113623 | |
| 0.011 | 0.087 | 0.151 | Motilin receptor agonist | 0.151 0.004 CID_113623 | CID_113623 | |
| 0.141 | 0.223 | 0.245 | Peptidyltransferase inhibitor | 0.245 0.054 CID_113623 | CID_113623 | |
| 0.021 | 0.114 | 0.036 | Antibiotic Aminoglycoside-like | 0.036 0.025 CID_113623 | CID_113623 | |
| 0.099 | 0.196 | 0.265 | Hepatoprotectant | 0.265 0.039 CID_113623 | CID_113623 | |
| 0.161 | 0.269 | 0.268 | Interleukin 2 agonist | 0.268 0.1 CID_113623 | CID_113623 | |
| 0.014 | 0.192 | 0.066 | Liver X receptor agonist | 0.066 0.014 CID_113623 | CID_113623 | |
| 0.071 | 0.27 | 0.265 | Interleukin antagonist | 0.265 0.056 CID_113623 | CID_113623 | |
| 0.074 | 0.325 | 0.215 | Antioxidant | 0.215 0.105 CID_113623 | CID_113623 | |
| 0.035 | 0.46 | 0.193 | Antimitotic | 0.193 0.088 CID_113623 | CID_113623 | |
| 0.009 | 0.621 | 0.135 | Topoisomerase I inhibitor | 0.135 0.048 CID_113623 | CID_113623 | |
| 0.008 | 0.705 | 0.14 | Neurotrophic factor | 0.14 0.069 CID_113623 | CID_113623 | |
| 0.019 | 0.806 | 0.351 | Immunomodulator | 0.351 0.059 CID_113623 | CID_113623 | |
| 0.008 | 0.847 | 0.136 | Cell adhesion inhibitor | 0.136 0.055 CID_113623 | CID_113623 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |